# Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814

> **NCT00403585** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 80 (actual)

## Conditions studied

- Hepatitis B, Chronic
- Chronic Hepatitis B

## Interventions

- **DRUG:** adefovir dipivoxil 10mg

## Key facts

- **NCT ID:** NCT00403585
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2010-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00403585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00403585, "Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00403585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*